阿奇霉素序贯疗法治疗小儿支原体肺炎的临床观察.docVIP

阿奇霉素序贯疗法治疗小儿支原体肺炎的临床观察 　　摘要：目的 总结阿奇霉素序贯疗法治疗小儿支原体肺炎的临床效果。方法 将我院儿科小儿支原体肺炎患者92例纳入，随机分组。A组患儿临床用药方案为持续静脉滴注阿奇霉素治疗；B组患儿临床用药方案为阿奇霉素序贯疗法，将两组患儿治疗后的治疗效果、临床症状消退时间、用药不良现象发生情况、治疗成本进行对比。结果 A、B两组治疗效果差异不显著P0.05。临床症状消退时间、用药安全性、治疗成本方面，B组均优于A组，P0.05。结论 应用阿奇霉素序贯治疗小儿支原体肺炎的有效性高，可促进患儿临床症状迅速缓解，且用药安全性高，可节省医疗费用，值得推广。 　　关键词：小儿支原体肺炎；临床治疗成果；阿奇霉素 　　Abstract：Objective To summarize the clinical effect of Azithromycin Sequential Therapy in treatment of children with mycoplasma pneumonia.Methods 92 cases of pediatric mycoplasma pneumonia in our hospital from February 2014 to May 2015 were included in the study.In the A group，the clinical treatment plan for continuous intravenous infusion of azithromycin treatment；B group of children with clinical medication for the treatment of azithromycin，the two groups of patients after treatment efficacy，clinical symptoms subside time，medication adverse phenomenon，treatment costs were compared.Results From the treatment effect，the total effective rate of B group was 95.65%，the total effective rate of A group was 91.30%，the difference was not significant P0.05.From the clinical symptoms disappeared time.B group sputum，fever，breathing，chest X-ray shadow fade time were shorter in group P0.05.From the safety of drug use，B group was significantly less than P0.05.From the treatment cost，the B group was significantly less than that in the A group P0.05.Conclusion The application of azithromycin in the treatment of mycoplasma pneumonia in children is effective，and can promote the clinical symptoms of the children quickly，and the safety of drug use，can save medical expenses，it is worth promoting. 　　Key words：pediatric mycoplasma pneumonia；Clinical outcome；Azithromycin 　　肺炎支原体为呼吸道主要感染病原体，其属于病毒和细菌之间的微生物，具有细胞形态，通过呼吸道感染后可进入血液到全身各个组织。患病后需及时采取措施治疗，避免病情迁延[1]。临床多用大环内酯类药物治疗，本文选取小儿支原体肺炎患者92例，总结阿奇霉素序贯疗法治疗小儿支原体肺炎的临床效果，将其跟口服阿奇霉素进行对比，报道如下。 　　1资料与方法 　　1.1一般资料 研究将我院儿科2014年2月～2015年5月小儿支原体肺炎患者92例纳入，纳入标准为符合小儿支原体肺炎诊断标准[2]，所有家长签署知情同意书。所有患儿临床表现为：发热、咳痰、咳嗽，部分患儿出现胸闷、憋气、喘气、胸痛等表现，将其按住院编号